J. Goldman & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-67,306
| Closed | -$1.09M | – | 238 |
|
|
2022
Q1 | $1.09M | Buy |
+67,306
| New | +$1.09M | 0.05% | 176 |
|
|
2020
Q4 | – | Sell |
-118,125
| Closed | -$406K | – | 280 |
|
|
2020
Q3 | $406K | Sell |
118,125
-241,819
| -67% | -$831K | 0.03% | 190 |
|
|
2020
Q2 | $1.72M | Buy |
+359,944
| New | +$1.72M | 0.11% | 132 |
|